Asia Pacific Manufacturing Execution System (MES) In Life Sciences Market Forecast to 2033–COVID-19 Impact and Regional Analysis– by Offering (Software and Services), Deployment (On-Premises and Cloud), Organization Size (SMEs and Large Enterprises), and Application (Pharmaceutical, Biotechnology, and Medical Devices)
The Asia Pacific manufacturing execution system in life sciences market is expected to grow from US$ 834.86 million in 2023 to US$ 2,821.07 million by 2033. It is estimated to grow at a CAGR of 12.9% from 2023 to 2033.
Rising Application in Cell and Gene Therapy Sector Fuels Asia Pacific Manufacturing Execution System (MES) In Life Sciences Market
Cell and gene therapy is one of the growing divisions of the healthcare industry. The growth in the clinical adoption of advanced cell therapy is one of the major factors raising the demand for personalized medicines. In addition, the growing demand for cell therapy and the promise it holds further raise the requirement for MES solutions. It is seen that cell therapy is moving from a manual-oriented lab environment to identifying production scale principles to make the process more robust and error-free with reduced costs. In the cell therapy process, MES can help automate the tracking of the patient’s blood cells through the system and thus offer significant valuable insights for the treatment been manufactured. Furthermore, electronic verification of the process negates human error and can improve a lab's throughput. In addition, the MES solution can also help reduce risk by alerting operators about problems that could have catastrophic consequences. Several market players are also providing MES solutions, particularly for cell and gene manufacturing. For example, POMS Corporation provides POMSnet MES. The MES solution helps regulate industry deliveries such as genealogy, material management, and equipment tracking (instruments, safety hoods, centrifuges, and more). Also, the electronic batch record execution helps manufacturers deliver cell therapies faster by streamlining the production workflow with a cloud-based MES.
There is also an increasing number of collaborations between key solution providers of the pharmaceutical manufacturing industry’s ecosystem for developing advanced solutions for cell and gene therapy product manufacturing. In January 2022, TrakCel, a supplier of cellular orchestration solutions for the cell and gene therapy industry, collaborated with Korber for software integration. The collaboration resulted in a functional integration between TrakCel’s OCELLOS and Korber’s PAS-X. It is expected to allow both companies' cell and gene therapy customers to effectively share data detailing manufacturing events and milestones such as starting checks, fill and finish, and product release; and provide full traceability and audit logs. Thus, the growing application and adoption of MES by the market players in cell and gene therapy manufacturing is expected to create an opportunity for the growth of the manufacturing execution system in life sciences market during the forecast period.
Asia Pacific Manufacturing Execution System (MES) In Life Sciences Market Overview
The MES in life sciences market in Asia Pacific is sub-segmented into China, India, Japan, Australia, South Korea, and the Rest of Asia Pacific. Various growing economies in the region are witnessing automation in life sciences industries. The healthcare sector in Asia Pacific is flourishing with growth in foreign investments from western countries, especially from Europe and North America. The manufacturing execution systems bring substantial improvements over paper-based processes. They help pharma manufacturers to create flawless manufacturing processes; reduce risks, time, costs, and efforts; and increase process efficiency and product quality. To surpass China in pharma and biotech capabilities, India is continuously substantiating the ecosystem for pharmaceutical manufacturer in the country. Furthermore, the pharmaceutical industry in India is continuously looking for advanced methods to ease manufacturing operations.
Asia Pacific Manufacturing Execution System (MES) In Life Sciences Market Revenue and Forecast to 2033 (US$ Million)
Get more information on this report :
Asia Pacific Manufacturing Execution System (MES) In Life Sciences Market Segmentation
The Asia Pacific manufacturing execution system in life sciences market is segmented into offering, deployment, organization size, application, and country.
Based on offering, the Asia Pacific manufacturing execution system in life sciences market is segmented into software and services. The services segment held a larger share of the Asia Pacific manufacturing execution system in life sciences market in 2023.
Based on deployment, the Asia Pacific manufacturing execution system in life sciences market is segmented into on-premises and cloud. The cloud segment held a larger share of the Asia Pacific manufacturing execution system in life sciences market in 2023.
Based on organization size, the Asia Pacific manufacturing execution system in life sciences market is segmented into SMEs and large enterprises. The large enterprises segment held the largest share of the Asia Pacific manufacturing execution system in life sciences market in 2023.
Based on application, the Asia Pacific manufacturing execution system in life sciences market is segmented into pharmaceutical, biotechnology, and medical devices. The medical devices segment held the largest share of the Asia Pacific manufacturing execution system in life sciences market in 2023.
Based on country, the Asia Pacific manufacturing execution system in life sciences market is segmented into Australia, China, India, Japan, South Korea, and the Rest of Asia Pacific. China dominated the share of the Asia Pacific manufacturing execution system in life sciences market in 2023.
Atachi Systems; ATS Global B.V.; Emerson Electric Co; LZ Lifescience Limited; Rockwell Automation Inc; Schneider Electric SE; and Siemens AG are the leading companies operating in the Asia Pacific manufacturing execution system in life sciences market.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Asia Pacific Manufacturing Execution System in Life Sciences Market – By Offering
1.3.2 Asia Pacific Manufacturing Execution System in Life Sciences Market – By Deployment
1.3.3 Asia Pacific Manufacturing Execution System in Life Sciences Market – By Organization Size
1.3.4 Asia Pacific Manufacturing Execution System in Life Sciences Market – By Application
1.3.5 Asia Pacific Manufacturing Execution System in Life Sciences Market – By Country
2. Asia Pacific Manufacturing Execution System in Life Sciences Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Asia Pacific Manufacturing Execution System in Life Sciences Market – Market Landscape
4.1 Overview
4.2 Asia Pacific PEST Analysis
4.3 Ecosystem Analysis
4.4 Expert Opinion
5. Asia Pacific Manufacturing Execution System in Life Sciences Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Need for Compliance with Regulatory Framework
5.1.2 Requirement of Accurate Real-Time Data in Production Management Process
5.2 Market Restraints
5.2.1 High Cost and Lack of Flexibility
5.3 Market Opportunities
5.3.1 Rising Application in Cell and Gene Therapy Sector
5.4 Future Trends
5.4.1 Shift from Legacy to Modern MES
5.4.2 Rise in Adoption of Pharma 4.0
5.5 Impact Analysis of Drivers and Restraints
6. Manufacturing Execution System in Life Sciences Market – Asia Pacific Analysis
6.1 Asia Pacific Manufacturing Execution System in Life Sciences Market Overview
6.2 Asia Pacific Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
7. Asia Pacific Manufacturing Execution System in Life Sciences Market Analysis – By Offering
7.1 Overview
7.2 Asia Pacific Manufacturing Execution System in Life Sciences Market, By Offering (2022 and 2033)
7.3 Software
7.3.1 Overview
7.3.2 Software: Asia Pacific Manufacturing Execution System in Life Sciences Market – Revenue, and Forecast to 2033 (US$ Million)
7.4 Services
7.4.1 Overview
7.4.2 Services: Asia Pacific Manufacturing Execution System in Life Sciences Market – Revenue, and Forecast to 2033 (US$ Million)
8. Asia Pacific Manufacturing Execution System in Life Sciences Market Analysis – By Deployment
8.1 Overview
8.2 Asia Pacific Manufacturing Execution System in Life Sciences Market, By Deployment (2022 and 2033)
8.3 On-Premises
8.3.1 Overview
8.3.2 On-Premises: Asia Pacific Manufacturing Execution System in Life Sciences Market – Revenue, and Forecast to 2033 (US$ Million)
8.4 Cloud
8.4.1 Overview
8.4.2 Cloud: Asia Pacific Manufacturing Execution System in Life Sciences Market – Revenue, and Forecast to 2033 (US$ Million)
9. Asia Pacific Manufacturing Execution System in Life Sciences Market Analysis – By Organization Size
9.1 Overview
9.2 Asia Pacific Manufacturing Execution System in Life Sciences Market, By Organization Size (2022 and 2033)
9.3 SMEs
9.3.1 Overview
9.3.2 SMEs: Asia Pacific Manufacturing Execution System in Life Sciences Market – Revenue, and Forecast to 2033 (US$ Million)
9.4 Large Enterprises
9.4.1 Overview
9.4.2 Large Enterprises: Asia Pacific Manufacturing Execution System in Life Sciences Market – Revenue, and Forecast to 2033 (US$ Million)
10. Asia Pacific Manufacturing Execution System in Life Sciences Market Analysis – By Application
10.1 Overview
10.2 Asia Pacific Manufacturing Execution System in Life Sciences Market, By Application (2022 and 2033)
10.3 Pharmaceutical
10.3.1 Overview
10.3.2 Pharmaceutical: Asia Pacific Manufacturing Execution System in Life Sciences Market – Revenue, and Forecast to 2033 (US$ Million)
10.4 Biotechnology
10.4.1 Overview
10.4.2 Biotechnology: Asia Pacific Manufacturing Execution System in Life Sciences Market – Revenue, and Forecast to 2033 (US$ Million)
10.5 Medical Devices
10.5.1 Overview
10.5.2 Medical Devices: Asia Pacific Manufacturing Execution System in Life Sciences Market – Revenue, and Forecast to 2033 (US$ Million)
11. Asia Pacific Manufacturing Execution System in Life Sciences Market Analysis – By Country
11.1 Overview
11.1.1 Asia Pacific Manufacturing Execution System in Life Sciences Market, by Country, 2022 & 2033 (%)
11.1.1.1 Australia: Asia Pacific Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
11.1.1.1.1 Overview
11.1.1.1.2 Australia: Asia Pacific Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
11.1.1.1.3 Australia: Asia Pacific Manufacturing Execution System in Life Sciences Market, by Offering, 2022–2033 (US$ Million)
11.1.1.1.4 Australia: Asia Pacific Manufacturing Execution System in Life Sciences Market, by Deployment, 2022–2033 (US$ Million)
11.1.1.1.5 Australia: Asia Pacific Manufacturing Execution System in Life Sciences Market, Organization Size, 2022–2033 (US$ Million)
11.1.1.1.6 Australia: Asia Pacific Manufacturing Execution System in Life Sciences Market, by Application, 2022–2033 (US$ Million)
11.1.1.2 China: Asia Pacific Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
11.1.1.2.1 Overview
11.1.1.2.2 China: Asia Pacific Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
11.1.1.2.3 China: Asia Pacific Manufacturing Execution System in Life Sciences Market, by Offering, 2022–2033 (US$ Million)
11.1.1.2.4 China: Asia Pacific Manufacturing Execution System in Life Sciences Market, by Deployment, 2022–2033 (US$ Million)
11.1.1.2.5 China: Asia Pacific Manufacturing Execution System in Life Sciences Market, Organization Size, 2022–2033 (US$ Million)
11.1.1.2.6 China: Asia Pacific Manufacturing Execution System in Life Sciences Market, by Application, 2022–2033 (US$ Million)
11.1.1.3 India: Asia Pacific Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
11.1.1.3.1 Overview
11.1.1.3.2 India: Asia Pacific Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
11.1.1.3.3 India: Asia Pacific Manufacturing Execution System in Life Sciences Market, by Offering, 2022–2033 (US$ Million)
11.1.1.3.4 India: Asia Pacific Manufacturing Execution System in Life Sciences Market, by Deployment, 2022–2033 (US$ Million)
11.1.1.3.5 India: Asia Pacific Manufacturing Execution System in Life Sciences Market, Organization Size, 2022–2033 (US$ Million)
11.1.1.3.6 India: Asia Pacific Manufacturing Execution System in Life Sciences Market, by Application, 2022–2033 (US$ Million)
11.1.1.4 Japan: Asia Pacific Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
11.1.1.4.1 Overview
11.1.1.4.2 Japan: Asia Pacific Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
11.1.1.4.3 Japan: Asia Pacific Manufacturing Execution System in Life Sciences Market, by Offering, 2022–2033 (US$ Million)
11.1.1.4.4 Japan: Asia Pacific Manufacturing Execution System in Life Sciences Market, by Deployment, 2022–2033 (US$ Million)
11.1.1.4.5 Japan: Asia Pacific Manufacturing Execution System in Life Sciences Market, Organization Size, 2022–2033 (US$ Million)
11.1.1.4.6 Japan: Asia Pacific Manufacturing Execution System in Life Sciences Market, by Application, 2022–2033 (US$ Million)
11.1.1.5 South Korea: Asia Pacific Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
11.1.1.5.1 Overview
11.1.1.5.2 South Korea: Asia Pacific Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
11.1.1.5.3 South Korea: Asia Pacific Manufacturing Execution System in Life Sciences Market, by Offering, 2022–2033 (US$ Million)
11.1.1.5.4 South Korea: Asia Pacific Manufacturing Execution System in Life Sciences Market, by Deployment, 2022–2033 (US$ Million)
11.1.1.5.5 South Korea: Asia Pacific Manufacturing Execution System in Life Sciences Market, Organization Size, 2022–2033 (US$ Million)
11.1.1.5.6 South Korea: Asia Pacific Manufacturing Execution System in Life Sciences Market, by Application, 2022–2033 (US$ Million)
11.1.1.6 Rest of Asia Pacific: Asia Pacific Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
11.1.1.6.1 Overview
11.1.1.6.2 Rest of Asia Pacific: Asia Pacific Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
11.1.1.6.3 Rest of Asia Pacific: Asia Pacific Manufacturing Execution System in Life Sciences Market, by Offering, 2022–2033 (US$ Million)
11.1.1.6.4 Rest of Asia Pacific: Asia Pacific Manufacturing Execution System in Life Sciences Market, by Deployment, 2022–2033 (US$ Million)
11.1.1.6.5 Rest of Asia Pacific: Asia Pacific Manufacturing Execution System in Life Sciences Market, Organization Size, 2022–2033 (US$ Million)
11.1.1.6.6 Rest of Asia Pacific: Asia Pacific Manufacturing Execution System in Life Sciences Market, by Application, 2022–2033 (US$ Million)
12. Industry Landscape
12.1 Overview
12.2 Market Initiatives, Expansions, and Strategic Developments
12.3 New Product/Feature Development
12.4 Mergers and Acquisitions
12.5 Agreements, Collaborations, and Joint Ventures
13. Company Profiles
13.1 ATS Global B.V.
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Atachi Systems
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Emerson Electric Co
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 LZ Lifescience Limited
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Rockwell Automation Inc
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Schneider Electric SE
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Siemens AG
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Word Index
LIST OF TABLES
Table 1. Asia Pacific Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2023 (US$ Million)
Table 2. Australia: Asia Pacific Manufacturing Execution System in Life Sciences Market, by Offering – Revenue and Forecast to 2033 (US$ Million)
Table 3. Australia: Asia Pacific Manufacturing Execution System in Life Sciences Market, by Deployment – Revenue and Forecast to 2033 (US$ Million)
Table 4. Australia: Asia Pacific Manufacturing Execution System in Life Sciences Market, Organization Size – Revenue and Forecast to 2033 (US$ Million)
Table 5. Australia: Asia Pacific Manufacturing Execution System in Life Sciences Market, by Application – Revenue and Forecast to 2033 (US$ Million)
Table 6. China: Asia Pacific Manufacturing Execution System in Life Sciences Market, by Offering – Revenue and Forecast to 2033 (US$ Million)
Table 7. China: Asia Pacific Manufacturing Execution System in Life Sciences Market, by Deployment – Revenue and Forecast to 2033 (US$ Million)
Table 8. China: Asia Pacific Manufacturing Execution System in Life Sciences Market, Organization Size – Revenue and Forecast to 2033 (US$ Million)
Table 9. China: Asia Pacific Manufacturing Execution System in Life Sciences Market, by Application – Revenue and Forecast to 2033 (US$ Million)
Table 10. India: Asia Pacific Manufacturing Execution System in Life Sciences Market, by Offering – Revenue and Forecast to 2033 (US$ Million)
Table 11. India: Asia Pacific Manufacturing Execution System in Life Sciences Market, by Deployment – Revenue and Forecast to 2033 (US$ Million)
Table 12. India: Asia Pacific Manufacturing Execution System in Life Sciences Market, Organization Size – Revenue and Forecast to 2033 (US$ Million)
Table 13. India: Asia Pacific Manufacturing Execution System in Life Sciences Market, by Application – Revenue and Forecast to 2033 (US$ Million)
Table 14. Japan: Asia Pacific Manufacturing Execution System in Life Sciences Market, by Offering – Revenue and Forecast to 2033 (US$ Million)
Table 15. Japan: Asia Pacific Manufacturing Execution System in Life Sciences Market, by Deployment – Revenue and Forecast to 2033 (US$ Million)
Table 16. Japan: Asia Pacific Manufacturing Execution System in Life Sciences Market, Organization Size – Revenue and Forecast to 2033 (US$ Million)
Table 17. Japan: Asia Pacific Manufacturing Execution System in Life Sciences Market, by Application – Revenue and Forecast to 2033 (US$ Million)
Table 18. South Korea: Asia Pacific Manufacturing Execution System in Life Sciences Market, by Offering – Revenue and Forecast to 2033 (US$ Million)
Table 19. South Korea: Asia Pacific Manufacturing Execution System in Life Sciences Market, by Deployment – Revenue and Forecast to 2033 (US$ Million)
Table 20. South Korea: Asia Pacific Manufacturing Execution System in Life Sciences Market, Organization Size – Revenue and Forecast to 2033 (US$ Million)
Table 21. South Korea: Asia Pacific Manufacturing Execution System in Life Sciences Market, by Application – Revenue and Forecast to 2033 (US$ Million)
Table 22. Rest of Asia Pacific: Asia Pacific Manufacturing Execution System in Life Sciences Market, by Offering – Revenue and Forecast to 2033 (US$ Million)
Table 23. Rest of Asia Pacific: Asia Pacific Manufacturing Execution System in Life Sciences Market, by Deployment – Revenue and Forecast to 2033 (US$ Million)
Table 24. Rest of Asia Pacific: Asia Pacific Manufacturing Execution System in Life Sciences Market, Organization Size – Revenue and Forecast to 2033 (US$ Million)
Table 25. Rest of Asia Pacific: Asia Pacific Manufacturing Execution System in Life Sciences Market, by Application – Revenue and Forecast to 2033 (US$ Million)
Table 26. List of Abbreviation
LIST OF FIGURES
Figure 1. Asia Pacific Manufacturing Execution System in Life Sciences Market Segmentation
Figure 2. Asia Pacific Manufacturing Execution System in Life Sciences Market Segmentation, By Country
Figure 3. Asia Pacific Manufacturing Execution System in Life Sciences Market Overview
Figure 4. Services Held Largest Share Of Offering Segment In Asia Pacific Manufacturing Execution System in Life Sciences Market
Figure 5. India Is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. Asia Pacific: PEST Analysis
Figure 7. Expert Opinion
Figure 8. Asia Pacific Manufacturing Execution System in Life Sciences Market: Impact Analysis of Drivers and Restraints
Figure 9. Asia Pacific Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
Figure 10. Asia Pacific Manufacturing Execution System in Life Sciences Market Revenue Share, By Offering (2022 and 2033)
Figure 11. Software: Asia Pacific Manufacturing Execution System in Life Sciences Market – Revenue, and Forecast to 2033 (US$ Million)
Figure 12. Services: Asia Pacific Manufacturing Execution System in Life Sciences Market – Revenue, and Forecast to 2033 (US$ Million)
Figure 13. Asia Pacific Manufacturing Execution System in Life Sciences Market Revenue Share, By Deployment (2022 and 2033)
Figure 14. On-Premises: Asia Pacific Manufacturing Execution System in Life Sciences Market – Revenue, and Forecast to 2033 (US$ Million)
Figure 15. Cloud: Asia Pacific Manufacturing Execution System in Life Sciences Market – Revenue, and Forecast to 2033 (US$ Million)
Figure 16. Asia Pacific Manufacturing Execution System in Life Sciences Market Revenue Share, By Organization Size (2022 and 2033)
Figure 17. SMEs: Asia Pacific Manufacturing Execution System in Life Sciences Market – Revenue, and Forecast to 2033 (US$ Million)
Figure 18. Large Enterprises: Asia Pacific Manufacturing Execution System in Life Sciences Market – Revenue, and Forecast to 2033 (US$ Million)
Figure 19. Asia Pacific Manufacturing Execution System in Life Sciences Market Revenue Share, By Application (2022 and 2033)
Figure 20. Pharmaceutical: Asia Pacific Manufacturing Execution System in Life Sciences Market – Revenue, and Forecast to 2033 (US$ Million)
Figure 21. Biotechnology: Asia Pacific Manufacturing Execution System in Life Sciences Market – Revenue, and Forecast to 2033 (US$ Million)
Figure 22. Medical Devices: Asia Pacific Manufacturing Execution System in Life Sciences Market – Revenue, and Forecast to 2033 (US$ Million)
Figure 23. Asia Pacific Manufacturing Execution System in Life Sciences Market, by Key Country – Revenue (2022) (US$ Million)
Figure 24. Australia: Asia Pacific Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
Figure 25. China: Asia Pacific Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
Figure 26. India: Asia Pacific Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
Figure 27. Japan: Asia Pacific Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
Figure 28. South Korea: Asia Pacific Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
Figure 29. Rest of Asia Pacific: Asia Pacific Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
- Atachi Systems
- ATS Global B.V.
- Emerson Electric Co
- LZ Lifescience Limited
- Rockwell Automation Inc
- Schneider Electric SE
- Siemens AG